PRIDE III Prison Interventions and HIV Prevention Collaboration
Recruiting
N/A
Interventional Study
Hiv
Opioid Use
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 300 (estimated)
- Sponsor
- Yale University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The primary objective of this research project is to identify barriers to scale-up of Opioid Agonist Therapy (OAT) in the justice systems (prisons and probation) in Tajikistan, Kyrgyzstan, Moldova, and Georgia, and establish a NIATx learning collaborative to scale-up OAT, and analyze scale-up utilizing latent class growth analyses in people who inject drugs (PWID).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Aim 1:
1. Quantitative surveys for prison OAT providers
* Being 18 years or older
* Being currently assigned and working as a probation OAT provider for a probation site
2. ECHO procedures
Aim 2:
1. Quantitative surveys for people in probation
* Being 18 years or o…
Contacts